| MeSH term | MeSH ID | Detail |
|---|---|---|
| Neoplasms, Squamous Cell | D018307 | 1 associated lipids |
| Osteoporotic Fractures | D058866 | 1 associated lipids |
| Hemangioma, Capillary | D018324 | 1 associated lipids |
| Dentin Dysplasia | D003805 | 1 associated lipids |
| Cleidocranial Dysplasia | D002973 | 1 associated lipids |
| Prediabetic State | D011236 | 1 associated lipids |
| Scleroderma, Limited | D045745 | 1 associated lipids |
| Rheumatic Fever | D012213 | 1 associated lipids |
| Chronic Periodontitis | D055113 | 1 associated lipids |
| Intracranial Hemorrhage, Traumatic | D020198 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Widschwendter M et al. | Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629528 |
| Rachner TD and Rauner M | RANKL/OPG in Breast Cancer - Extending Its Territory to BRCA Mutation Carriers. | 2015 | EBioMedicine | pmid:26629502 |
| Niu Y et al. | Association of osteoprotegerin with impaired glucose regulation and microalbuminuria: the REACTION study. | 2015 | BMC Endocr Disord | pmid:26626139 |
| Miao Q et al. | Expression of osteoprotegerin, RNAK and RANKL genes in femoral head avascular necrosis and related signaling pathway. | 2015 | Int J Clin Exp Pathol | pmid:26617755 |
| Goswami S and Sharma-Walia N | Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. | 2015 | BMC Cancer | pmid:26608463 |
| Mrozikiewicz-Rakowska B et al. | Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. | 2015 | J. Physiol. Pharmacol. | pmid:26579581 |
| Kurz K et al. | Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. | 2015 | Dis. Markers | pmid:26576067 |
| Liu W et al. | Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. | 2015 | PLoS ONE | pmid:26571489 |
| Kulcsar-Jakab E et al. | Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study. | 2015 | BMC Musculoskelet Disord | pmid:26311162 |
| Silva Vde O et al. | β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. | 2015 | PLoS ONE | pmid:26291983 |
| Darabi H et al. | Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women. | 2015 | Medicine (Baltimore) | pmid:26287420 |
| Gennaro G et al. | Green Tea Modulates Cytokine Expression in the Periodontium and Attenuates Alveolar Bone Resorption in Type 1 Diabetic Rats. | 2015 | PLoS ONE | pmid:26270535 |
| Niu Y et al. | Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes. | 2015 | BMC Cardiovasc Disord | pmid:26260869 |
| Marley K et al. | Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL. | 2015 | Exp. Cell Res. | pmid:26254896 |
| McCarthy NI et al. | Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development. | 2015 | J. Immunol. | pmid:26254339 |
| Grosjean F et al. | Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. | 2015 | PLoS ONE | pmid:26247358 |
| Lewis JR et al. | Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. | 2015 | PLoS ONE | pmid:26222774 |
| Audo R et al. | Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. | 2015 | Arthritis Res. Ther. | pmid:26220665 |
| Wang J et al. | RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. | 2015 | PLoS ONE | pmid:26218592 |
| Weichhaus M et al. | Osteoprotegerin in breast cancer: beyond bone remodeling. | 2015 | Mol. Cancer | pmid:26054853 |
| Kastritis E et al. | Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. | 2015 | Blood Cancer J | pmid:26047389 |
| Ye M et al. | Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. | 2015 | Mol Med Rep | pmid:26459042 |
| Janda K et al. | Cardiovascular risk in chronic kidney disease patients: intima-media thickness predicts the incidence and severity of histologically assessed medial calcification in radial arteries. | 2015 | BMC Nephrol | pmid:26037625 |
| Davenport C et al. | The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes. | 2015 | Eur. J. Endocrinol. | pmid:26036811 |
| Harrison R et al. | Acute bone response to whole body vibration in healthy pre-pubertal boys. | 2015 | J Musculoskelet Neuronal Interact | pmid:26032203 |
| Goyden J et al. | The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation. | 2015 | PLoS ONE | pmid:26030441 |
| Beederman M et al. | Osteoprotegerin deficiency results in disruption of posterofrontal suture closure in mice: implications in nonsyndromic craniosynostosis. | 2015 | Plast. Reconstr. Surg. | pmid:26017615 |
| Tanaka Y et al. | [Mesenchymal stem cells for the treatment and repair of inflammatory arthritis]. | 2015 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:26016635 |
| Priyadarshi S et al. | Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. | 2015 | Ann. Hum. Genet. | pmid:25998045 |
| Yang Y et al. | The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. | 2015 | J. Biol. Chem. | pmid:25979341 |
| Ehlken C et al. | Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. | 2015 | PLoS ONE | pmid:25978399 |
| Zhao L et al. | Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. | 2015 | J. Nutr. Biochem. | pmid:26239832 |
| Xiong L et al. | Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. | 2015 | Proc. Natl. Acad. Sci. U.S.A. | pmid:25733894 |
| Qiao B et al. | Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. | 2015 | Drug Des Devel Ther | pmid:25733814 |
| Choe CH et al. | Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. | 2015 | FEBS Lett. | pmid:25728277 |
| de Molon RS et al. | OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. | 2015 | J. Bone Miner. Res. | pmid:25727550 |
| Nagy V and Penninger JM | The RANKL-RANK Story. | 2015 | Gerontology | pmid:25720990 |
| Han J et al. | [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. | 2015 | Beijing Da Xue Xue Bao | pmid:25686326 |
| Yang X et al. | Effects of TGF-β1 on OPG/RANKL expression of cementoblasts and osteoblasts are similar without stress but different with mechanical compressive stress. | 2015 | ScientificWorldJournal | pmid:25685846 |
| Chung CP et al. | A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. | 2015 | Int J Mol Sci | pmid:25679449 |
| HaDuong JH et al. | Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. | 2015 | Int. J. Cancer | pmid:25648303 |
| Higgs JT et al. | Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. | 2015 | Mol. Cancer Res. | pmid:25636966 |
| Lanza D et al. | Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. | 2015 | PLoS ONE | pmid:25635832 |
| Kuroyanagi G et al. | Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. | 2015 | Mol Med Rep | pmid:26044505 |
| Lee CJ et al. | Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. | 2015 | J. Atheroscler. Thromb. | pmid:25318352 |
| Maser RE et al. | Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes. | 2015 | Endocr Pract | pmid:25100392 |
| Nash LA et al. | Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. | 2015 | Mol Nutr Food Res | pmid:25488131 |
| Jin Y et al. | Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. | 2015 | Angle Orthod | pmid:24810489 |
| Kelesidis T et al. | Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. | 2014 Jul-Sep | AIDS Rev | pmid:25102334 |
| Bastos MF et al. | Impact of caffeine and/or estrogen deficiency on trabecular bone area and healing: a study in rats. | 2014 Jan-Feb | Int J Oral Maxillofac Implants | pmid:24451874 |
| Sagar DR et al. | Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. | 2014 | Ann. Rheum. Dis. | pmid:23723320 |
| Bjerre M et al. | Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. | 2014 | Scand. J. Clin. Lab. Invest. | pmid:25026506 |
| Tang ZL et al. | An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone. | 2014 | J. Oral Maxillofac. Surg. | pmid:24071373 |
| Zhao H et al. | Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. | 2014 | Br. J. Nutr. | pmid:24073920 |
| Nakashima T | [Coupling and communication between bone cells]. | 2014 | Clin Calcium | pmid:24870836 |
| Shimamura M et al. | OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:24847069 |
| Ghorbanihaghjo A et al. | Osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in exudative age-related macular degeneration. | 2014 | Acta Med Iran | pmid:24901855 |
| Dzgoeva FU et al. | [Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease]. | 2014 | Ter. Arkh. | pmid:25095658 |
| Honma M et al. | Regulatory mechanisms of RANKL presentation to osteoclast precursors. | 2014 | Curr Osteoporos Rep | pmid:24477414 |
| Lewis JR et al. | Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. | 2014 | Am. J. Nephrol. | pmid:24457210 |
| Cao H et al. | Preoperative serum receptor activator of nuclear factor-κB ligand/osteoprotegerin predict stabilization of spontaneously restored sinus rhythm in persistent atrial fibrillation patients after mitral valve surgery. | 2014 | Cardiology | pmid:24434592 |
| Miller RE et al. | RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. | 2014 | J Thorac Oncol | pmid:24496001 |
| Wang F et al. | Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. | 2014 | Biomed Res Int | pmid:25580430 |
| Ostrowska Z et al. | Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women. | 2014 | Endokrynol Pol | pmid:25554611 |
| Shen A et al. | Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. | 2014 | Medicine (Baltimore) | pmid:25546658 |
| Dessein PH et al. | Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. | 2014 | J. Rheumatol. | pmid:24488413 |
| Irtiuga OB et al. | [Concentration of osteoprotegerin and RANKL in blood serum of patients with aortic stenosis]. | 2014 | Kardiologiia | pmid:25178077 |
| Tella SH and Gallagher JC | Prevention and treatment of postmenopausal osteoporosis. | 2014 | J. Steroid Biochem. Mol. Biol. | pmid:24176761 |
| Lenglet S et al. | Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. | 2014 | Mediators Inflamm. | pmid:24648660 |
| Takeshita S et al. | Age-related marrow adipogenesis is linked to increased expression of RANKL. | 2014 | J. Biol. Chem. | pmid:24753250 |
| Akiyama T et al. | Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain. | 2014 | J. Biol. Chem. | pmid:24755218 |
| Davaine JM et al. | Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. | 2014 | PLoS ONE | pmid:25259713 |
| Zhang Z et al. | High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the RANKL/OPG ratio. | 2014 | Int J Mol Sci | pmid:25257532 |
| Kang JH et al. | Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis. | 2014 | J. Dent. Res. | pmid:25256714 |
| Cao H et al. | Force-induced Adrb2 in periodontal ligament cells promotes tooth movement. | 2014 | J. Dent. Res. | pmid:25252876 |
| Prates TP et al. | NOD2 contributes to Porphyromonas gingivalis-induced bone resorption. | 2014 | J. Dent. Res. | pmid:25239844 |
| Yamamoto N et al. | Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. | 2014 | Int. J. Mol. Med. | pmid:25234201 |
| Olivares-Navarrete R et al. | Osteoblast lineage cells can discriminate microscale topographic features on titanium-aluminum-vanadium surfaces. | 2014 | Ann Biomed Eng | pmid:25227453 |
| Giuliani AL et al. | Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. | 2014 | PLoS ONE | pmid:25226385 |
| Köttstorfer J et al. | Are OPG and RANKL involved in human fracture healing? | 2014 | J. Orthop. Res. | pmid:25212894 |
| Pullisaar H et al. | Simvastatin coating of TiOâ‚‚ scaffold induces osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells. | 2014 | Biochem. Biophys. Res. Commun. | pmid:24704451 |
| Chaganti RK et al. | Elevation of serum tumor necrosis factor α in patients with periprosthetic osteolysis: a case-control study. | 2014 | Clin. Orthop. Relat. Res. | pmid:24307062 |
| Liu YD et al. | Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. | 2014 | Osteoarthr. Cartil. | pmid:24316289 |
| Kuroyanagi G et al. | Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling. | 2014 | Arch. Biochem. Biophys. | pmid:24333336 |
| Simpson CA et al. | Serum levels of sclerostin, Dickkopf-1, and secreted frizzled-related protein-4 are not changed in individuals with high bone mass causing mutations in LRP5. | 2014 | Osteoporos Int | pmid:24927689 |
| Fuernau G et al. | Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. | 2014 | Eur. J. Heart Fail. | pmid:24903195 |
| Knevel R et al. | A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis. | 2014 | Arthritis Res. Ther. | pmid:24886600 |
| Zinonos I et al. | Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer. | 2014 | Int. J. Oncol. | pmid:24865346 |
| Klimek E et al. | Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. | 2014 | Mediators Inflamm. | pmid:24864133 |
| Chen H et al. | Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation. | 2014 | J. Bone Miner. Res. | pmid:24862038 |
| Li B et al. | Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system. | 2014 | Stem Cells Dev. | pmid:24827498 |
| Lee SI et al. | NOD2 Mediates Odontoblast Differentiation and RANKL Expression. | 2014 | J. Dent. Res. | pmid:24820666 |
| Araújo AA et al. | Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. | 2014 | PLoS ONE | pmid:24819928 |
| Inubushi T et al. | Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis. | 2014 | Arch. Oral Biol. | pmid:24370195 |
| Huang JW et al. | Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. | 2014 | Nutr Metab Cardiovasc Dis | pmid:24361071 |
| Jiang XY et al. | TNFRSF11B polymorphisms are associated with metabolic traits in Uyghur and Han ethnic groups. | 2014 | Endocr. Res. | pmid:23772656 |
| Pobeha P et al. | Circulatory osteoprotegerin is related to osteoporosis of the hip in patients with COPD. | 2014 | Respir Med | pmid:24424018 |
| Kinney JS et al. | Crevicular fluid biomarkers and periodontal disease progression. | 2014 | J. Clin. Periodontol. | pmid:24303954 |
| Chauvat A et al. | Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans. | 2014 | Hum Vaccin Immunother | pmid:24084262 |
| Chaichanasakul T et al. | Diverse osteoclastogenesis of bone marrow from mandible versus long bone. | 2014 | J. Periodontol. | pmid:24003963 |